Karolinska Development AB (publ)

KDEVFOTCHealthcare

$0.26

+$0.00(+0.00%)

Market Cap$68850739

P/E Ratio—

52W High$0.61328

52W Low$0.2576

Avg Volume0

Open$0.26

Beta0.24

Overview

Karolinska Development AB (publ) (KDEVF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

KDEVF · free cash flow · updated Jun 9, 2026

Core FCF metrics

KDEVF · FCF · TTM · margin & CAGR

Free cash flow was $73.6M for FY2023 (fiscal year ending 2023-12-31), up 326.1% year-over-year Five-year CAGR stands at +41.1%.

FY2023 Free Cash Flow$73.6M▲ +326.1% YoY

Trailing 12M (TTM)−$26.3MTrailing 4Q sum · TTM negative vs latest FY positive

FCF Margin> 999%$73.6M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR+41.1%FY2018 → FY2023

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

KDEVF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2023Latest−$25.0M(99M)$73.6M▲ +326.1%—

FY2022−$32.5M(0M)−$32.5M▼ 416.5%—

FY2021$16.7M(6M)$10.3M▲ +110.7%473.7%

FY2020−$33.2M(63M)−$95.9M▼ 342.5%—

FY2019−$7.4M(47M)$39.5M▲ +200.7%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

KDEVF · P/FCF · FCF yield · FCF per share

Karolinska Development AB (publ) (KDEVF) valuation ratios are currently unavailable — market cap, share count, or TTM data could not be retrieved from our data provider.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

Valuation ratios are unavailable — market cap, share count, or TTM data could not be retrieved. Individual metrics are shown where available.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2023 · 2023-12-31

Cash flow statement summary

KDEVF · cash flow statement · operating / investing / financing

For FY2023, Karolinska Development AB (publ) generated −$25.0M in operating cash flow and spent 99M in capital expenditures, yielding $73.6M in free cash flow.

Operating Activities

−$25.0M

Cash from core business operations

2023-12-31

Investing Activities

−$20.0M

CapEx, acquisitions & investments

2023-12-31

Financing Activities

−$0.8M

Buybacks, dividends & debt

2023-12-31

FCF FormulaOperating CF (−$25.0M) − |CapEx| (99M) = FCF ($73.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

KDEVF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Karolinska Development AB (publ)YOU

KDEVF

$73.6M+326.1%2620.9%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Karolinska Development AB (publ) (KDEVF) reported free cash flow of $73.6M for FY2023 (fiscal year ending 2023-12-31), up 326.1% year-over-year.

Based on available data, Karolinska Development AB (publ) has maintained positive free cash flow for at least 5 fiscal year(s). FCF peaked at $73.6M in FY2023. The 5-year CAGR stands at +41.1%.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

KDEVF free cash flow · 8 questions

Karolinska Development AB (publ) free cash flow was $73.6M for FY2023, up 326.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$26.3M.

KDEVF free cash flowKDEVF FCFKDEVF FCF 2023KDEVF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Karolinska Development AB (publ) · Karolinska Development AB (publ) SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026